COMBIMATRIX CORPORATION | 2,562 Euro | -0,067 -2,55 % | |
| WKN: A1J9L5 ISIN: US20009T3032 Ticker-Symbol: AZG4 | Frankfurt | 17.05.13 | 15:35 Uhr |
Branche NanotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 08.05. | CombiMatrix Management Discusses Q1 2013 Results - Earnings Call Transcript | - | Seeking Alpha | |
| 06.05. | CombiMatrix Executes Equity Financing | 50 | AFX News | |
| WASHINGTON (dpa-AFX) - CombiMatrix Corp. (CBMX), a molecular diagnostics
company performing DNA-based testing services for developmental disorders and
cancer, has inked an agreement to issue... Mehr lesen zu: CombiMatrix Executes Equity Financing | ||||
| 06.05. | CombiMatrix Corp - 8-K, Current Report | 1 | SEC Filings | |
| 26.04. | CombiMatrix Corp - 10-K/A, Annual Report | 3 | SEC Filings | |
| 04.04. | CombiMatrix Reports Preliminary Quarterly Growth in Prenatal Testing Volumes of 124% for First Quarter | 3 | Benzinga.com | |
| 04.04. | CombiMatrix (CBMX) Sees Record Prenatal Testing Volume in Q113 | 4 | StreetInsider.com | |
| 20.03. | CombiMatrix Announces $2 Mln Registered Direct Offering | 69 | AFX News | |
| WASHINGTON (dpa-AFX) - CombiMatrix Corp. (CBMX) said Wednesday that it has
entered into an agreement to issue securities in a registered direct offering to
an existing institutional investor... Mehr lesen zu: CombiMatrix Announces $2 Mln Registered Direct Offering | ||||
| 18.03. | CombiMatrix Potential Turnaround | 11 | Seeking Alpha | |
| 13.03. | New Assays, Enhanced Solutions Drive Momentum - Research Report on Quest Diagnostics, Life Technologies, LabCorp, Health Net, and CombiMatrix | 77 | PR Newswire | |
| NEW YORK, March 13, 2013 /PRNewswire/ --
Today, Investors Alliance announced new research reports highlighting Quest Diagnostics Incorporated (NYSE: DGX), Life Technologies Corporation (NASDAQ: LIFE)... Mehr lesen zu: New Assays, Enhanced Solutions Drive Momentum - Research Report on Quest Diagnostics, Life Technologies, LabCorp, Health Net, and CombiMatrix | ||||
| 27.02. | CombiMatrix Management Discusses Q4 2012 Results - Earnings Call Transcript | 2 | Seeking Alpha | |
| 25.02. | Shares of CombiMatrix Under Pressure, Down 6.1% | 4 | SmarTrend | |
| 25.02. | Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings | 56 | PR Newswire | |
| NEW YORK, February 25, 2013 /PRNewswire/ --
Today, Investors Alliance announced new research reports highlighting CombiMatrix Corporation (NASDAQ: CBMX), Cepheid (NASDAQ: CPHD), PerkinElmer, Inc.... Mehr lesen zu: Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings | ||||
| 23.02. | CombiMatrix Names New CEO | - | Motley Fool | |
| 22.02. | Mark McDonough Named New CEO of CombiMatrix | 3 | Benzinga.com | |
| 21.02. | Shares of CombiMatrix More Than Double Following Bullish Seeking Alpha Piece | 5 | Benzinga.com | |
| 21.02. | Stock Investors Bid Up Shares of CombiMatrix, Up 69.6% | 5 | SmarTrend | |
| 21.02. | Why CombiMatrix Shares Will Double By The End Of The Month | 15 | Seeking Alpha | |
| 23.01. | Lowest Price to Sales Ratio in the Life Sciences Tools & Services Industry Detected in Shares of CombiMatrix | 7 | SmarTrend | |
| 08.01. | CombiMatrix Bearish Moving Average Crossover Alert | 6 | SmarTrend | |
| 07.01. | CombiMatrix Up on Heavy Volume in Possible Trend Reversal | 4 | SmarTrend | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| HEADWATERS | 8,732 | +0,29 % | Headwaters has the Lowest Return on Equity in the Construction Materials Industry |
| ACACIA RESEARCH | 18,114 | -0,34 % | Acacia Research is Among the Companies in the Research and Consulting Services Industry With the Lowest PEG Ratio |
| NOVAVAX | 1,536 | -2,54 % | Novavax Initiates Animal Testing of H7N9 Nanoparticle VLP Influenza Vaccine |
| PSIVIDA | 2,157 | +1,46 % | PSIVIDA CORP.: Form 10-Q |
| DIVERSA | 0,01 | 0 % | XFRA XA6: WIEDERAUFNAHME/RESTART |
